Turning Biological Complexity into R&D Advantage with Virtual Cells - with Giorgio Gaglia of Sanofi & Daniel Veres of Turbine

Welcome, everyone, to the Emerge AI in Business podcast. Today's guests are Daniil Varese, co-founder and chief scientific officer at Turbine, a company building virtual cell models to stimulate how cells respond to genetic and chemical perturbations, and Giorgio Gaglia, Head of Systems and Disease Biology at Sanofi.

It goes beyond the title with direct discussion of think, where, virtual, including: Today's guests are Daniil Varese, co-founder and chief scientific officer at Turbine, a company building virtual cell models to stimulate how cells respond to genetic and chemical.

1. 01Today's guests are Daniil Varese, co-founder and chief scientific officer at Turbine, a company building virtual cell models to stimulate how cells respond to genetic and chemical
2. 02Together, they discuss why the most practical unit today is a narrow virtual assay built around a specific experiment, how blind, held-out data builds confidence in a model's predi
3. 03Just a quick note for our audience that the views expressed by Torjo on today's program do not reflect that of Sanofi or its leadership